Calithera Biosciences (NASDAQ:CALA) Now Covered by StockNews.com

Equities researchers at StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a note issued to investors on Tuesday. The brokerage set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Stock Down 83.3 %

CALA opened at $0.00 on Tuesday. Calithera Biosciences has a fifty-two week low of $0.00 and a fifty-two week high of $0.12.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.